Serum vascular endothelial growth factor levels in various liver diseases. 1998

F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
Second Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.

The clinical significance of circulating vascular endothelial growth factor (VEGF) in patients with various liver diseases was investigated. Twenty-one patients with acute hepatitis (AH), 40 with chronic hepatitis (CH), 34 with cirrhosis (LC), 16 with fulminant hepatitis (FH), 10 with primary biliary cirrhosis (PBC), 12 with autoimmune hepatitis (AIH), and 120 healthy individuals were included. Serum VEGF levels were measured by a chemiluminescence enzyme-linked immunosorbent assay. The mean values of serum VEGF levels in the patients with AH, CH, LC, FH, AIH, PBC, and control were 172.7, 58.0, 44.1, 37.3, 49.7, 74.9, and 65.0 pg/ml, respectively. The patients with AH had a level of serum VEGF significantly higher than that of the control group (P < 0.001). The serum VEGF levels in survivors of FH were significantly increased, but not in the nonsurvivors in the recovery phase compared with the levels on admission (P < 0.05). In the LC patients, serum VEGF levels were significantly lower than those of the control group (P < 0.05). These findings suggest that serum VEGF level may be associated with hepatocyte regeneration grade.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
May 2022, The Journal of veterinary medical science,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
June 1999, Digestive diseases and sciences,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
January 2017, Annals of gastroenterology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
December 2002, Journal of the Egyptian Society of Parasitology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
December 2019, Archives of rheumatology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
January 2000, Acta obstetricia et gynecologica Scandinavica,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
December 1998, The British journal of dermatology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
January 2003, Hepato-gastroenterology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
January 2004, European neurology,
F Akiyoshi, and M Sata, and H Suzuki, and Y Uchimura, and K Mitsuyama, and K Matsuo, and K Tanikawa
June 2001, Leukemia,
Copied contents to your clipboard!